What a year 2024 has been for Trace Neuroscience, with one of the largest biopharma Series A rounds in recent years funding the development of a treatment for amyotrophic lateral sclerosis (ALS), which affects 5000 people in the UK. UCLB played a crucial role in supporting the

Earlier this year, @UCL spinout company Autolus Therapeutics announced that the U.S. Food and Drug Administration (FDA) had granted marketing approval for AUCATZYL® (obecabtagene autoleucel, obe-cel), for the treatment of adult patients with relapsed or refractory B-cell

It’s been an unforgettable year for Oriole Networks, with the UCLB spinout securing $13m in seed funding to accelerate development of its ‘all-optical’ infrastructure, enabling Large Language Models (LLMs) to be trained up to a hundred times faster with AI inference significantly

In 2024 the Spinout Review anniversary has shown further commitment to nurturing university research and innovation. Spinouts represent the bridge between groundbreaking research and real-world impact, generating jobs, driving economic growth, and transforming lives. The

A great end to the year for the EnAcuity team. The UCLB and Imperial College London spinout has secured £1.28 million pre-seed funding in a round led by Twin Path Ventures, joined by the London Co-Investment Fund and Crista Galli Ventures. The team are looking to further build and

Season’s Greetings from everyone at UCLB! There have been so many milestone moments in 2024 from our work with UCL’s academic entrepreneurs, where we have continued to bring research and innovations to market to provide a positive real-world impact. We look forward to many more

The Financial Times has run a piece highlighting UCLB spinout Autolus Therapeutics’ journey to produce therapies for cancer side effects 👏 The news story focuses on the work taking place at Autolus’ Stevenage facility, which is manufacturing the latest generation of an

UCLH and GSL’s partnership brings diagnostics hope for Parkinson’s and other diseases 🤝 A new partnership between UCLH and Guilford Street Laboratories (GSL) will combine next generation testing, artificial intelligence, advanced mass spectrometry and machine learning to

🔊 Calling UCL academics! Don't miss our next I/O Lab Coffee Club session with Professor George Zervas (UCL's Department of Electronic and Electrical Engineering) and James Regan, co-founders of UCL spinout Oriole Networks. Discover more and sign up here:

Sifted shines a spotlight on the university-affiliated venture funds supporting spinouts, with 92% of the UK’s Russell Group universities now having an affiliated venture fund. AlbionVC UCL Business Ltd Sifted Read more: sifted.eu/articles/russe…

Last chance to sign up for tomorrow's I/O Lab Coffee Club event. Join us in conversation with Professor George Zervas (UCL EEE) and James Regan, co-founders of UCL spinout Oriole Networks. More here ⬇️

Thanks to those who joined us yesterday for another great I/O Lab Coffee Club session with co-founders of UCL spinout Oriole Networks, Professor George Zervas and James Regan. We look forward to seeing you at the next Coffee Club event 👏 UCL | UCL Technology Fund | UCL Engineering |

🧬 Register Now for the UCL Advanced Therapies Symposium 2025! Join 250+ experts to explore gene therapy, emerging technologies, rare diseases, and more. 🗓️9 April 2025, 09:00–19:00 📍UCL Great Ormond Street Institute Book your ticket: bit.ly/4gyenWT #UCL2025AdvTx

We’re pleased to be part of the coalition of universities – launched today - calling for more Proof of Concept funding to fuel innovation and economic growth from the commercialisation of university research. UCLB is proud to have created a £7.5m POC fund which has supported a

Today is #WorldCancerDay – At UCLB we are so proud of the work our spinouts do to bring hope to millions 👏 Fighting cancer is among medicine’s biggest challenges, and several UCLB spinouts are rising to meet that challenge by bringing to market groundbreaking treatments and

Get to know more about UCL spinout Odin Vision, a company developing #AI software to improve endoscopic procedures for better early detection and diagnosis of cancer. We recently chatted to Professor Dan Stoyanov , Scientific Advisor at Odin, to learn about his experiences of

The winners of the Creating Impact Through Knowledge Exchange Awards 2025 were announced yesterday at Senate House. It was a fantastic evening which recognised and celebrated knowledge exchange activity across every corner of UCL. Read the article: bit.ly/40NV31C

Join us at the UCL Advanced Therapies Symposium 2025, featuring an unmissable panel discussion on Innovation & Commercialisation, featuring industry and academic leaders. Book your ticket today! Early bird rates end 28 February. bit.ly/4gyenWT UCL Business Ltd